Effect of local dual frequency sonication on drug distribution from polymeric nanomicelles

Ultrasonics Sonochemistry

Volumn 18, Issue 5, 2011, Pages 1165-1171

  Hasanzadeh, Hadi ^a,b   Mokhtari Dizaji, Manijhe ^a   Zahra Bathaie, S ^a   Hassan, Zuhair M ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acoustic cavitation; Breast adenocarcinoma; Drug delivery; Nanotechnology; Ultrasound

Indexed keywords

ACOUSTIC FIELDS; CAVITATION; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; DRUG DOSAGE; HISTOLOGY; MICELLES; NANOTECHNOLOGY; POLYMERS; SONICATION; TUMORS; ULTRASONICS;

ACOUSTIC CAVITATIONS; BREAST ADENOCARCINOMA; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; POLYMERIC MICELLE; POLYMERIC NANOMICELLES; SYSTEMIC ADMINISTRATION; ULTRASOUND IRRADIATION;

TARGETED DRUG DELIVERY;

DOXORUBICIN; PLURONIC P 105; POLOXAMER; UNCLASSIFIED DRUG;

ACOUSTICS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG STABILITY; DRUG TISSUE LEVEL; DRUG UPTAKE; EXCITATION; FEMALE; FLUOROMETRY; FREQUENCY MODULATION; HEART; KIDNEY; LIVER; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; PLASMA; PRIORITY JOURNAL; SPECTROPHOTOMETRY; SPLEEN; TISSUE HOMOGENATE; TUMOR; TUMOR LOCALIZATION; ULTRASOUND;

EID: 84943010224     PISSN: 13504177     EISSN: 18732828     Source Type: Journal    
DOI: 10.1016/j.ultsonch.2011.03.018     Document Type: Article

References (37)

1. W. Lauterborn, T. Kurz, R. Geisler, D. Schanz, O. Lindau, Acoustic cavitation, bubble dynamics and sonoluminescence, Ultrason. Sonochem. 14 (2007) 484-491. (Pubitemid 46330096)
2. R. Feng, Y. Zhao, C. Zhu, T.J. Mason, Enhancement of ultrasonic cavitation yield by multi-frequency sonication, Ultrason. Sonochem. 9 (2002) 231-236.
3. A.H. Barati, M. Mokhtari-Dizaji, H. Mozdarani, S.Z. Bathaie, Z.M. Hassan, Effect of exposure parameters on cavitation induced by low-level dual-frequency ultrasound, Ultrason. Sonochem. 14 (2007) 783-789.
4. G. Husseini, G. Myrup, W. Pitt, D. Christensen, N. Rapoport, Factors affecting acoustically triggered release of drugs from polymeric micelles, J. Contr. Release 69 (2000) 43-52.
5. G. Husseini, D. Christensen, N. Rapoport, W. Pitt, Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N,N-diethylacrylamide, J. Contr. Release 83 (2002) 303-305. (Pubitemid 35282472)
6. G. Husseini, M.D. Rosa, T. Gabuji, Y. Zeng, D. Christensen, W. Pitt, Release of doxorubicin from unstablized and stabilized micelles under the action of ultrasound, J. Nanosci. Nanotechnol. 7 (2007) 1028-1033.
7. A. Marine, M. Muniruzzaman, N. Rapoport, Acoustic activation of drug delivery from polymeric micelles: effect of pulsed ultrasound, J. Contr. Release 71 (2001) 239-249. (Pubitemid 32276044)
8. Z. Gao, H. Fain, N. Rapoporrt, Controlled and targeted tumor chemotherapy by micellar encapsulated drug and ultrasound, J. Contr. Release 102 (2005) 203-222. (Pubitemid 40093786)
9. I. Larina, B. Evers, T. Ashitkov, C. Bartels, K. Larin, R. Esenaliev, Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation, Technol. Cancer Res. Treat. 4 (2005) 217-226. (Pubitemid 40559049)
10. J. Nelson, B. Roeder, J. Carmen, F. Roloff, W. Pitt, Ultrasonically activated chemotherapeutic drug delivery in a rat model, Cancer Res. 62 (2002) 7280-7283. (Pubitemid 36025250)
11. A. Kümmerle, T. Krueger, M. Dusmet, C. Vallet, Y. Pan, H.B. Ris, L.A. Decosterd, A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements, J. Pharm. Biomed. Anal. 33 (2003) 475-494. (Pubitemid 37206472)
12. P.E. Colombo, M. Boustta, S. Poujol, F. Pinguet, P. Rouanet, F. Bressolle, M. Vert, Biodistribution of doxorubicin-alkylated poly (l-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration, Eur. J. Pharm. Sci. 31 (2007) 43-52. (Pubitemid 46604790)
13. V. Alakhov, E. Klinski, S. Li, G. Pietrzynski, A. Venne, E. Batrakova, T. Bronitch, A. Kabanov, Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials, Colloids. Surf. B. Biointerfaces 16 (1999) 113-134. (Pubitemid 29486800)
14. A.M.M. Osman, M.M. Nemnem, A.A. Abou-Bakr, O.A. Nassier, M.T. Khayyal, Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice, Food Chem. Toxicol. 47 (2009) 2425-2430.
15. A. Fundar, R. Cavalli, A. Bargoni, D. Vighetto, G.P. Zara, M.R. Gasco, Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats, Pharmacol. Res. 42 (2000) 337-343.
16. G.J.R. Charrois, T.M. Allen, Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer, Biochim. Biophys. Acta 1663 (2004) 167-177. (Pubitemid 38625591)
17. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, S. Inoue, Polymer micelles as novel drug carrier: adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer, J. Contr. Release 11 (1990) 269-278. (Pubitemid 20070104)
18. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, S. Inoue, Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)- poly(aspartic acid) block copolymer, Cancer Res. 50 (1990) 1693-1700. (Pubitemid 20098806)
19. Y.I. Jeong, H.S. Na, K.O. Cho, H.C. Lee, J.W. Nah, C.S. Cho, Antitumor activity of adriamycin-incorporated polymeric micelles of poly([gamma]-benzyl l-glutamate)/ poly(ethylene oxide), Int. J. Pharm. 365 (2009) 150-156.
20. H.L. Wong, A.M. Rauth, R. Bendayan, X.Y. Wu, In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model, Eur. J. Pharm. Biopharm. 65 (2007) 300-308.
21. R.K. Subedi, K.W. Kang, H.K. Choi, Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin, Eur. J. Pharm. Sci. 37 (2009) 508-513.
22. K. Kazunori, S.K. Glenn, Y. Masayuki, O. Teruo, S. Yasuhisa, Block copolymer micelles as vehicles for drug delivery, J. Contr. Release 24 (1993) 119-132.
23. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, R. Langer, Biodegradable long-circulating polymeric nanospheres, Science 263 (1994) 1600-1603. (Pubitemid 24128361)
24. M. Yokoyama, T. Okano, Y. Sakurai, H. Ekimoto, C. Shibazaki, K. Kataoka, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood, Cancer Res. 51 (1991) 3229-3236.
25. A. Miwa, A. Ishibe, M. Nakano, T. Yamahira, S. Itai, S. Jinno, H. Kawahara, Development of novel chitosan derivatives as micellar carriers of taxol, Pharm. Res. 15 (1998) 1844-1850.
26. Y.I. Son, J.S. Jang, Y.W. Cho, H. Chung, R.W. Park, I.C. Kwon, I.S. Kim, J.Y. Park, S.B. Seo, C.R. Park, S.Y. Jeong, Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect, J. Contr. Release 91 (2003) 135-145. (Pubitemid 37288884)
27. H.S. Yoo, T.G. Park, Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer, J. Contr. Release 70 (2001) 63-70. (Pubitemid 32144793)
28. D.C. Bibby, J.E. Talmadge, M.K. Dalal, S.G. Kurz, K.M. Chytil, S.E. Barry, D.G. Shand, M. Steiert, Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice, Int. J. Pharm. 293 (2005) 281-290.
29. A.M. Al-Abd, N.H. Kim, S.C. Song, S.J. Lee, H.J. Kuh, A simple HPLC method for doxorubicin in plasma and tissues of nude mice, Arch. Pharm. Res. 32 (2009) 605-611.
30. T.E. Mürdter, B. Sperker, K. Bosslet, P. Fritz, H.K. Kroemer, Simultaneous high-performance liquid chromatographic determination of a glucuronyl prodrug of doxorubicin, doxorubicin and its metabolites in human lung tissue, J. Chromatogr. B. Biomed. Sci. Appl. 709 (1998) 289-295.
31. S.R. Urva, B.S. Shin, V.C. Yang, J.P. Balthasar, Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues, J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 877 (2009) 837-841.
32. R. Ricciarello, S. Pichini, R. Pacifici, I. Altieri, M. Pellegrini, A. Fattorossi, P. Zuccaro, Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection, J. Chromatogr. B. Biomed. Sci. Appl. 707 (1998) 219-225.
33. D. Kim, Z.G. Gao, E.S. Lee, Y.H. Bae, In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer, Mol. Pharm. 6 (2009) 1353-1362.
34. R.D. Arnold, J.E. Slack, R.M. Straubinger, Quantification of doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy, J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 808 (2004) 141-152. (Pubitemid 38952908)
35. H. Hasanzadeh, M. Mokhtari-Dizaji, S.Z. Bathaie, Z.M. Hassan, V. Nilchiani, H. Goudarzi, Enhancement and control of acoustic cavitation yield by low level dual frequency sonication: a subharmonic analysis, Ultrason. Sonochem. 18 (2011) 394-400.
36. 6 and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts, J. Contr. Release 61 (1999) 145-157.
37. Q. Zhou, B. Chowbay, Determination of doxorubicin and its metabolites in rat serum and bile by LC: application to preclinical pharmacokinetic studies, J. Pharm. Biomed. Anal. 30 (2002) 1063-1074. (Pubitemid 35284318)